Skip Nav Destination
Progress in Basic and Clinical Pharmacology
Clinical Pharmacology and Therapy of Helicobacter pylori Infection
S.Karger AG
Volume
11
Status:
Available
ISBN electronic:
978-3-318-01034-3
ISBN print:
978-3-8055-7658-1
Subject Area:
Pharmacology
Discontinued Book Series:
Progress in Basic and Clinical Pharmacology
Publication date:
2004
Clinical Pharmacology and Therapy of Helicobacter pylori Infection
Edited by: C. Scarpignato, G. Bianchi Porro
https://doi.org/10.1159/isbn.978-3-318-01034-3
ISBN (print): 978-3-8055-7658-1
ISBN (electronic): 978-3-318-01034-3
Publisher: S.Karger AG
Published: 2004
Download citation file:
Digital Version
Pay-Per-View Access
$351.00
Print Version
Clinical Pharmacology and Therapy of Helicobacter pylori Infection
$351.00
Table of Contents
-
1 - 19: Clinical Spectrum of Helicobacter pylori InfectionByD.Y. GrahamD.Y. GrahamaDepartments of Medicine andbDivision of Molecular Virology, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Tex., USASearch for other works by this author on:
-
20 - 42: Mechanisms of Helicobacter pylori-Induced Mucosal DamageByJ.E. Crabtree;J.E. CrabtreeaDivision of Medicine, St. James’s University Hospital, Leeds, UK, andSearch for other works by this author on:N. FiguraN. FigurabIstituto Patologica Speciale Medica, Policlinico Le Scotte, Siena, ItalySearch for other works by this author on:
-
43 - 56: Gastroduodenal Mucosal Damage: Interaction between NSAIDs and Helicobacter pylori InfectionByM. Lazzaroni;M. LazzaroniGI Unit, L. Sacco University Hospital, Milan, ItalySearch for other works by this author on:G. Bianchi PorroG. Bianchi PorroGI Unit, L. Sacco University Hospital, Milan, ItalySearch for other works by this author on:
-
57 - 73: Disturbances of Gastroduodenal Physiology in Helicobacter pylori InfectionByA. Gibbons;A. GibbonsDepartment of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, UKSearch for other works by this author on:J. CalamJ. CalamDepartment of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, UKSearch for other works by this author on:
-
74 - 84: Clinical Pharmacology of AntimicrobialsByS. GoodwinS. GoodwinDivision of Gastroenterology, Endocrinology and Metabolism, St. George’s Hospital Medical School, London, UKSearch for other works by this author on:
-
85 - 125: Bismuth Compounds for Eradication of Helicobacter pylori: Pharmacology and SafetyByC. Scarpignato;C. ScarpignatoaDepartment of Internal Medicine, School of Medicine and Dentistry, University of Parma, Italy, andbDepartment of Gastroenterology and Hepatology, Faculty of Medicine, University of Nantes, FranceSearch for other works by this author on:I. PelosiniI. PelosiniaDepartment of Internal Medicine, School of Medicine and Dentistry, University of Parma, Italy, andSearch for other works by this author on:
-
126 - 133: Sucralfate and Helicobacter pyloriByS. Marks;S. MarksGastrointestinal Clinic and Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South AfricaSearch for other works by this author on:J.A. LouwJ.A. LouwGastrointestinal Clinic and Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South AfricaSearch for other works by this author on:
-
134 - 178: Antisecretory Drugs for Eradication of Helicobacter pylori: Antibacterial Activity and Synergism with Antimicrobial AgentsByC. Scarpignato;C. ScarpignatoaDepartment of Internal Medicine, School of Medicine and Dentistry, University of Parma, Italy andbDepartment of Gastroenterology and Hepatology, Faculty of Medicine, University of Nantes, FranceSearch for other works by this author on:I. PelosiniI. PelosiniaDepartment of Internal Medicine, School of Medicine and Dentistry, University of Parma, Italy andSearch for other works by this author on:
-
179 - 188: Evaluation of Helicobacter pylori Eradication: Which Test?ByE. De Koster;E. De KosterDepartment of Gastroenterology, Brugmann University Hospital, Free University of Brussels (VUB–ULB), Brussels, BelgiumSearch for other works by this author on:C. Jonas;C. JonasDepartment of Gastroenterology, Brugmann University Hospital, Free University of Brussels (VUB–ULB), Brussels, BelgiumSearch for other works by this author on:P. Denis;P. DenisDepartment of Gastroenterology, Brugmann University Hospital, Free University of Brussels (VUB–ULB), Brussels, BelgiumSearch for other works by this author on:J. Otero;J. OteroDepartment of Gastroenterology, Brugmann University Hospital, Free University of Brussels (VUB–ULB), Brussels, BelgiumSearch for other works by this author on:M. DeltenreM. DeltenreDepartment of Gastroenterology, Brugmann University Hospital, Free University of Brussels (VUB–ULB), Brussels, BelgiumSearch for other works by this author on:
-
189 - 208: Helicobacter pylori Eradication: Drug RegimensByP. Moayyedi;P. MoayyediCenter for Digestive Diseases, Leeds General Infirmary, Leeds, UKSearch for other works by this author on:A.T.R. AxonA.T.R. AxonCenter for Digestive Diseases, Leeds General Infirmary, Leeds, UKSearch for other works by this author on:
-
209 - 246: Esomeprazole-Based Regimens for Helicobacter pylori Eradication (Updated Contents)ByC. Scarpignato;C. ScarpignatoaLaboratory of Clinical Pharmacology, School of Medicine and Dentistry, University of Parma andSearch for other works by this author on:I. Pelosini;I. PelosiniaLaboratory of Clinical Pharmacology, School of Medicine and Dentistry, University of Parma andSearch for other works by this author on:E. Molina;E. MolinaaLaboratory of Clinical Pharmacology, School of Medicine and Dentistry, University of Parma andSearch for other works by this author on:S. VigneriS. VigneribDepartment of Internal Medicine, School of Medicine and Dentistry, University of Palermo, ItalySearch for other works by this author on:
-
247 - 261: Quadruple Therapy: Second- or First-Line Eradication Regimen?ByW.A. de BoerW.A. de BoerDepartment of Internal Medicine, Saint Anna Hospital, Oss, NetherlandsSearch for other works by this author on:
-
262 - 303: Drug Therapy of Helicobacter pylori Infection: A Meta-Analysis
-
304 - 315: Drug Therapy of Helicobacter pylori Infection: A Pharmacoeconomic AnalysisByN.B. VakilN.B. VakilUniversity of Wisconsin Medical School, Milwaukee, Wisc., USASearch for other works by this author on:
-
316 - 328: Therapy of Helicobacter pylori-Positive Peptic Ulcer DiseaseByG. Maconi;G. MaconiGastrointestinal Unit, ‘L. Sacco’ University Hospital, Milan, ItalySearch for other works by this author on:G. Bianchi PorroG. Bianchi PorroGastrointestinal Unit, ‘L. Sacco’ University Hospital, Milan, ItalySearch for other works by this author on:
-
329 - 339: Therapy of Helicobacter pylori-Positive Nonulcer DyspepsiaByS. Montague;S. MontagueDepartment of Gastroenterology, Adelaide/Meath Hospital, Trinity College, Tallaght, Dublin, IrelandSearch for other works by this author on:D. McNamara;D. McNamaraDepartment of Gastroenterology, Adelaide/Meath Hospital, Trinity College, Tallaght, Dublin, IrelandSearch for other works by this author on:M. Buckley;M. BuckleyDepartment of Gastroenterology, Adelaide/Meath Hospital, Trinity College, Tallaght, Dublin, IrelandSearch for other works by this author on:C. O´MorainC. O´MorainDepartment of Gastroenterology, Adelaide/Meath Hospital, Trinity College, Tallaght, Dublin, IrelandSearch for other works by this author on:
-
340 - 351: Therapy of Helicobacter pylori-Associated Gastric NeoplasmsByA. Meining;A. MeiningaKlinikum rechts der Isar, TU München, 11 Medizinische Abteilung, MünchenSearch for other works by this author on:E. Bayerdörffer;E. BayerdörfferbI. Medizinische Abteilung der TU Dresden, andSearch for other works by this author on:M. StolteM. StoltecInstitute für Pathologie, Klinikum Bayreuth, GermanySearch for other works by this author on:
-
352 - 363: Treatment of Helicobacter pylori Eradication FailureByR.W.M. van der Hulst;R.W.M. van der HulstaDepartment of Gastroenterology, Academic Medical Center, Amsterdam, andbKennemer Gasthuis, Haarlem, The NetherlandsSearch for other works by this author on:G.N.J. TytgatG.N.J. TytgataDepartment of Gastroenterology, Academic Medical Center, Amsterdam, andSearch for other works by this author on:
-
364 - 380: Resistance of Helicobacter pylori to AntibioticsByF. MégraudF. MégraudLaboratoire de Bactériologie, Hôpital Pellegrin, and Université Victor Segalen Bordeaux 2, Bordeaux, FranceSearch for other works by this author on:
-
381 - 391: Treatment Options for Patients with Helicobacter pylori Infection Resistant to One or More Eradication Attempts (Updated Contents)ByF. Parente;F. ParenteChair of Gastroenterology, L. Sacco University Hospital, Milan, ItalySearch for other works by this author on:C. Cucino;C. CucinoChair of Gastroenterology, L. Sacco University Hospital, Milan, ItalySearch for other works by this author on:G. Bianchi PorroG. Bianchi PorroChair of Gastroenterology, L. Sacco University Hospital, Milan, ItalySearch for other works by this author on:
-
392 - 398: Treatment of Helicobacter pylori ReinfectionByS. Miehlke;S. MiehlkeaMedical Department I, Technical University Hospital Dresden, andSearch for other works by this author on:E. Bayerdörffer;E. BayerdörfferaMedical Department I, Technical University Hospital Dresden, andSearch for other works by this author on:P. MalfertheinerP. MalfertheinerbDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-v.-Guericke University, Magdeburg, GermanySearch for other works by this author on:
-
399 - 418: Progress toward Vaccination against Helicobacter pylori InfectionByA. CovacciA. CovaccibMolecular Biology, Immunobiological Research Institute Siena (IRIS), Chiron Biocine SpA, Siena, ItalySearch for other works by this author on:
-
419 - 435: Treatment of Helicobacter pylori Infection: From Today´s Practice to Future ManagementByM.P. Williams;M.P. WilliamsUniversity Department of Medicine, Royal Free and University College Medical School, London, UKSearch for other works by this author on:R.E. PounderR.E. PounderUniversity Department of Medicine, Royal Free and University College Medical School, London, UKSearch for other works by this author on:
-
436 - 455: Current Concepts in the Management of Helicobacter pylori Infection - The Maastricht 2-2000 Consensus Report (Updated Contents)ByP. Malfertheiner;P. MalfertheineraOtto-von-Guericke University of Magdeburg, Magdeburg, Germany;Search for other works by this author on:F. Mégraud;F. MégraudbHopital Pellegrin, Bordeaux, France;Search for other works by this author on:C. O´Morain;C. O´MoraincCharlemont Clinic, Dublin, Ireland;Search for other works by this author on:A.P.S. Hungin;A.P.S. HungindUniversity of Durham, Durham, UK;Search for other works by this author on:R. Jones;R. JoneseGuy’s, King’s and St Thomas’ School of Medicine, London, UK;Search for other works by this author on:A.T.R. Axon;A.T.R. AxonfThe General Infirmary at Leeds, Leeds, UK;Search for other works by this author on:D.Y. Graham;D.Y. GrahamgVA Medical Center Houston, Tex., USA; andSearch for other works by this author on:G.N.J. TytgatG.N.J. TytgathAcademisch Medisch Centrum Amsterdam, Amsterdam, The NetherlandsSearch for other works by this author on: